Evofem Biosciences, Inc. Quarterly Current Ratio in % from Q3 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Evofem Biosciences, Inc. quarterly Current Ratio history and growth rate from Q3 2015 to Q2 2024.
  • Evofem Biosciences, Inc. Current Ratio for the quarter ending June 30, 2024 was 12.1 %, a 40.3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 12.1 -8.17 -40.3% Jun 30, 2024
Q1 2024 14 -4.56 -24.6% Mar 31, 2024
Q4 2023 17 -0.1 -0.59% Dec 31, 2023
Q3 2023 16.9 -1.62 -8.73% Sep 30, 2023
Q2 2023 20.3 -2.45 -10.8% Jun 30, 2023
Q1 2023 18.5 -25.9 -58.3% Mar 31, 2023
Q4 2022 17.1 -52.3 -75.4% Dec 31, 2022
Q3 2022 18.6 -85.4 -82.1% Sep 30, 2022
Q2 2022 22.7 -108 -82.6% Jun 30, 2022
Q1 2022 44.4 -101 -69.5% Mar 31, 2022
Q4 2021 69.4 -86.4 -55.5% Dec 31, 2021
Q3 2021 104 -70.7 -40.5% Sep 30, 2021
Q2 2021 131 -67 -33.9% Jun 30, 2021
Q1 2021 145 -69.7 -32.4% Mar 31, 2021
Q4 2020 156 +4.71 +3.12% Dec 31, 2020
Q3 2020 175 +73.3 +72.2% Sep 30, 2020
Q2 2020 198 +130 +191% Jun 30, 2020
Q1 2020 215 +175 +442% Mar 31, 2020
Q4 2019 151 +104 +218% Dec 31, 2019
Q3 2019 101 +74.5 +277% Sep 30, 2019
Q2 2019 68.1 +41.8 +159% Jun 30, 2019
Q1 2019 39.7 +21.9 +123% Mar 31, 2019
Q4 2018 47.5 +22.3 +88.9% Dec 31, 2018
Q3 2018 26.9 -143 -84.2% Sep 30, 2018
Q2 2018 26.3 -184 -87.5% Jun 30, 2018
Q1 2018 17.8 -234 -92.9% Mar 31, 2018
Q4 2017 25.1 -261 -91.2% Dec 31, 2017
Q3 2017 170 -392 -69.7% Sep 30, 2017
Q2 2017 210 -275 -56.7% Jun 30, 2017
Q1 2017 251 -333 -57% Mar 31, 2017
Q4 2016 286 -445 -60.8% Dec 31, 2016
Q3 2016 562 -544 -49.2% Sep 30, 2016
Q2 2016 485 Jun 30, 2016
Q1 2016 584 Mar 31, 2016
Q4 2015 731 Dec 31, 2015
Q3 2015 1.11K Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.